Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LKQ Corporation (“LKQ” or the “Company”) (NASDAQ: LKQ). Such investors are...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE: PBH). Such...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET). Such...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against zSpace, Inc. (“zSpace” or the “Company”) (NASDAQ: ZSPC). Such investors are...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Globant SA (“Globant” or the “Company”) (NYSE: GLOB). Such investors are...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA). Such investors...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP). Such...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fitness Champs Holdings Ltd. (“FCHL” or the “Company”) (NASDAQ: FCHL). Such...
-
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ServBanc Holdco, Inc. (“ServBanc Holdco”), as successor in interest to IF...